Sam Salek

10.7k total citations · 3 hit papers
228 papers, 6.8k citations indexed

About

Sam Salek is a scholar working on Economics and Econometrics, Dermatology and Immunology. According to data from OpenAlex, Sam Salek has authored 228 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Economics and Econometrics, 40 papers in Dermatology and 37 papers in Immunology. Recurrent topics in Sam Salek's work include Health Systems, Economic Evaluations, Quality of Life (75 papers), Pharmaceutical Economics and Policy (53 papers) and Dermatology and Skin Diseases (35 papers). Sam Salek is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (75 papers), Pharmaceutical Economics and Policy (53 papers) and Dermatology and Skin Diseases (35 papers). Sam Salek collaborates with scholars based in United Kingdom, Germany and Italy. Sam Salek's co-authors include A.Y. Finlay, M.K.A. Basra, Stuart Walker, Charles L. Thomas, Yan HongBo, Michael Harrison, Ruben Gatt, Ghazala Khan, D K Luscombe and Faraz M Ali and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sam Salek

210 papers receiving 6.6k citations

Hit Papers

Translating the Science o... 2005 2026 2012 2019 2005 2008 2014 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Sam Salek 3.1k 1.5k 1.3k 1.0k 845 228 6.8k
Rajesh Balkrishnan 2.1k 0.7× 1.3k 0.9× 889 0.7× 743 0.7× 613 0.7× 195 6.9k
Mary‐Margaret Chren 4.2k 1.4× 945 0.6× 791 0.6× 919 0.9× 635 0.8× 142 8.0k
April W. Armstrong 6.3k 2.0× 8.6k 5.7× 1.1k 0.8× 1.2k 1.2× 1.8k 2.1× 493 14.0k
Marco DiBonaventura 1.3k 0.4× 299 0.2× 306 0.2× 893 0.9× 1.0k 1.2× 198 7.3k
Fabian Camacho 1.2k 0.4× 475 0.3× 893 0.7× 316 0.3× 335 0.4× 213 7.0k
Stephen P. McKenna 556 0.2× 680 0.5× 773 0.6× 261 0.3× 446 0.5× 154 6.0k
Adam Reich 4.2k 1.3× 1.9k 1.3× 120 0.1× 1.3k 1.3× 911 1.1× 348 7.5k
Matthias Augustin 9.2k 3.0× 7.9k 5.2× 1.7k 1.3× 2.4k 2.3× 1.9k 2.3× 821 17.5k
Ann E. Clarke 751 0.2× 3.2k 2.1× 365 0.3× 2.1k 2.0× 916 1.1× 304 11.2k
Rosa Parisi 1.6k 0.5× 2.8k 1.9× 316 0.2× 140 0.1× 407 0.5× 56 4.0k

Countries citing papers authored by Sam Salek

Since Specialization
Citations

This map shows the geographic impact of Sam Salek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Salek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Salek more than expected).

Fields of papers citing papers by Sam Salek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam Salek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Salek. The network helps show where Sam Salek may publish in the future.

Co-authorship network of co-authors of Sam Salek

This figure shows the co-authorship network connecting the top 25 collaborators of Sam Salek. A scholar is included among the top collaborators of Sam Salek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam Salek. Sam Salek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Salek, Sam, Faraz M Ali, Kennedy Otwombe, et al.. (2025). Multiple sclerosis greatly impacts family members/partners: Evidence using the Family Reported Outcome Measure (FROM-16). Multiple Sclerosis Journal - Experimental Translational and Clinical. 11(2). 3120701962–3120701962.
5.
Vyas, Jui, Jeffrey Johns, Faraz M Ali, et al.. (2024). P047 Dermatology Life Quality Index used as a standard in validation of 101 quality-of-life instruments: a systematic review. British Journal of Dermatology. 191(Supplement_1). i36–i36.
6.
Falcone, Robert E., et al.. (2024). Development of a Consumer Reported Outcome Measure for Personal Care Products : The Rationale. International Journal of Scientific Research in Science and Technology. 526–533. 1 indexed citations
7.
Finlay, A.Y., Faraz M Ali, Harris Allen, et al.. (2024). Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: A cross‐sectional study. European Journal Of Haematology. 113(1). 117–126. 4 indexed citations
8.
Finlay, A.Y., Faraz M Ali, Kennedy Otwombe, et al.. (2024). Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross‐sectional study. Diabetes Obesity and Metabolism. 27(2). 652–662. 1 indexed citations
9.
Finlay, A.Y., Sam Salek, Harris Allen, et al.. (2024). Responsiveness and minimal important change of the Family Reported Outcome Measure (FROM-16). Journal of Patient-Reported Outcomes. 8(1). 38–38. 7 indexed citations
11.
Ndomondo-Sigonda, Margareth, et al.. (2023). Regional regulatory harmonisation initiatives: Their potential contribution to the newly established African Medicines Agency. Regulatory Toxicology and Pharmacology. 145. 105497–105497. 3 indexed citations
12.
Masur, Clarissa, et al.. (2023). What do Hyperhidrosis Quality of Life Index (HidroQoL©) scores mean? Transferring science into practice by establishing a score banding system. British Journal of Dermatology. 190(4). 519–526. 1 indexed citations
13.
Finlay, A.Y., et al.. (2023). Meaning of Family Reported Outcome Measure (FROM-16) severity score bands: a cross-sectional online study in the UK. BMJ Open. 13(3). e066168–e066168. 8 indexed citations
14.
Lysen, Thom S., Hanne van Ballegooijen, Peter Rijnbeek, et al.. (2023). Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends. Drug Safety. 46(4). 405–416. 14 indexed citations
16.
Ali, Faraz M, et al.. (2021). Family reported outcomes, an unmet need in the management of a patient's disease: appraisal of the literature. Health and Quality of Life Outcomes. 19(1). 194–194. 20 indexed citations
17.
Chernyshov, Pavel V., Andrea W.M. Evers, Anthony Bewley, et al.. (2021). Quality of life assessment in core outcome sets: A position statement of the EADV Task Force on Quality of Life and Patient Oriented Outcomes. Journal of the European Academy of Dermatology and Venereology. 36(1). 20–23. 7 indexed citations
18.
Chernyshov, Pavel V., Swen Malte John, L. Tomás-Aragonés, et al.. (2020). Quality of life measurement in occupational skin diseases. Position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Occupational Skin Disease. Journal of the European Academy of Dermatology and Venereology. 34(9). 1924–1931. 13 indexed citations
19.
Ali, Faraz M, et al.. (2016). A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis. British Journal of Dermatology. 176(3). 577–593. 46 indexed citations
20.
Salek, Sam. (1996). Quality-of-Life Assessment in Patients on Peritoneal Dialysis: A Review of the State of the Art. Peritoneal Dialysis International. 16(2_suppl). 398–402. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026